The company says that in recent years, Omics techniques such as Genomics, Transcriptomics, Proteomics, and Metabolomics, have taken a central role in life science research. Understanding the spatiotemporal relationships between various biological components has become crucial for elucidating biological functions in both healthy and diseased states.
“SpectraPlex was developed to enable researchers to obtain more spatially resolved 3D data when interrogating complex disease states, allowing for a deeper analysis of pathological conditions,” said James O´Brien, Vice President of Life Sciences and Applied Solutions at Leica Microsystems. “The data acquired using SpectraPlex can propel the discovery of new cell types, the identification of cell states and the mapping of functional relationships in a 3D spatial context, aiding in the understanding of disease progression and the identification of potential therapeutic targets.”